Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Shyam Metalics' value-added expansion to help deliver on its long-term goals
Shyam Metalics targets a revenue CAGR of about 18% over FY26-FY31 and an Ebitda CAGR of 22%.
Nisus Finance to raise up to Rs 4,000 crore through a real assets investment platform
Nisus Finance is launching a real assets platform to raise up to Rs 4,000 crore, targeting yield-generating and value-accretive real estate opportunities across India. The platform will attract domestic and UAE-based investors, including family offices and ultra-high-net-worth individuals. A key vehicle, the Nisus Yield and Asset Multiplier Fund (NiYAM), will focus on structured credit and equity enhancement for projects like plotted developments and redevelopment.
AI model maker stock, after 2,000% rally in six months, plans share sale worth billions
Shares of Zhipu have more than doubled in value in just the last nine trading sessions, including a 12% advance on Wednesday. During this period, the stock has risen 135%.
City Union Bank to raise over Rs 500 crore through QIP
City Union Bank's board has greenlit a plan to raise up to ₹500 crore via a qualified institutional placement, pending shareholder nod at the August 14, 2026 AGM. This move aims to bolster the bank's capital. On the same day, shareholders will consider a ₹2 per share dividend for FY26, representing a 200% payout on the face value.
Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value
Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition in under a year, signals a growing trend of consolidation in the beauty and personal care sector. Honasa aims to integrate science-backed skincare with nutraceuticals, addressing consumer demand for holistic wellness solutions. Fluence Pharma will become the ninth brand under Honasa's umbrella.
Govt eyes fast-tracking local production of high-end medical devices
India is planning to boost local manufacturing of around 10 high-value medical devices, including MRI systems and pacemakers, to curb reliance on expensive imports. Industry consultations with the government are underway to identify key product categories for accelerated development. This initiative aims to address a significant rise in medical device imports, with potential policy support including tariff reviews and subsidies.
NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chain
Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think tank urges a shift towards high-value segments, emphasizing enhanced industry-academia collaboration for patent commercialization and startup incubation. While India is the 'pharmacy of the world,' it needs to move up the value chain by focusing on deeptech innovation to become a capital for pharma innovation.
Centre brings together states, industry for $100 billion textile exports goal
India aims to double its textile and apparel exports to $100 billion by 2030, with a nationwide exercise and summit focusing on strategies for key hubs. Discussions centered on technical textiles, man-made fibers, and improving logistics. The initiative emphasizes district-led growth and value addition to bolster the nation's global textile trade presence.
Promoter Twin Star sells Vedanta shares worth Rs 1,896 crore in block deal
Twin Star Holdings, a promoter entity of Vedanta, sold 6.51 crore shares worth nearly Rs 1,896 crore through a block deal on Tuesday. The transaction comes amid Vedanta's ongoing restructuring efforts following the listing of its demerged businesses and continued focus on debt reduction and value unlocking.
SpaceX falls below IPO price before rebounding 2%: Is it a second-chance buying opportunity?
SpaceX shares rebounded 2% after falling below $150, impacting its market valuation under $2 trillion. After a $75 billion IPO, investor sentiment weakened, with SpaceX losing over $600 billion in value post-IPO. Despite the volatility, shares remain 10% above the $135 IPO price.
Graphite India management to meet Kotak Mutual Fund on June 24 - scanx.trade
Graphite India management to meet Kotak Mutual Fund on June 24scanx.trade
Ahead of Market: 10 things that will decide stock market action on Wednesday
Sensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. Investors will track technical levels, global cues, FII activity and key stock movements on Wednesday as markets look for direction after the sharp decline.